Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure

Circulation Journal - Japan
doi 10.1253/circj.cj-15-0227
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Circulation Society

Related search

A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis

Gastroenterology
HepatologyGastroenterology
2008English

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2015English

Therapeutic Effect of Oral CF101 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

Immunome Research
2014English

Clinical Efficacy and Safety of Topiroxostat in Japanese Hyperuricemic Patients With or Without Gout: A Randomized, Double-Blinded, Controlled Phase 2b Study

Clinical Rheumatology
MedicineRheumatology
2016English

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Lipegfilgrastim in Patients With Non-Small Cell Lung Cancer Receiving Myelosuppressive Therapy

SpringerPlus
Multidisciplinary
2015English

Effects of Vedolizumab in Japanese Patients With Crohn’s Disease: A Prospective, Multicenter, Randomized, Placebo-Controlled Phase 3 Trial With Exploratory Analyses

Journal of Gastroenterology
Gastroenterology
2019English

Lithium as Add-On to Quetiapine XR in Adult Patients With Acute Mania: A 6-Week, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study

International Journal of Bipolar Disorders
PsychiatryMental HealthBiological Psychiatry
2014English

Efficacy and Safety of Trimodulin, a Novel Polyclonal Antibody Preparation, in Patients With Severe Community-Acquired Pneumonia: A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Trial (CIGMA Study)

Intensive Care Medicine
Critical CareIntensive Care Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy